Nilotinib in PH+, BCR-, ABL+ CML Patients

Clinical trial NCT01535391 · COMPLETED

Trial details

NCT number: NCT01535391
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2012-01-01
Primary completion: 2014-11-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.